// company-profile

Zymeworks Inc.

ZYME
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings73Insiders25
// api This Zymeworks Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Zymeworks Inc. insiders bought $0 across 11 transactions with no open-market sales.

  • Most active insider: Platshon Scott with 3 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Zymeworks Inc. as of 2026-03-31

— stable
Total reported AUM
$1.74B
QoQ change
+1.7%
Reporting period
2026-03-31
#1
EcoR1 Capital, LLC
CIK 1587114
$575.2M
23.0M shares
#2
Rubric Capital Management LP
CIK 1687509
$175.3M
7.0M shares
#3
BVF INC/IL
CIK 1056807
$93.5M
3.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 13, 2026Schneider Paul RZYME
Award
178,000$0.00$0K
May 13, 2026Schneider Paul RZYME
Award
119,000$0.00$0K
Apr 9, 2026Platshon ScottZYME
Award
47,000$0.00$0K
Apr 9, 2026Platshon ScottZYME
Award
76,000$0.00$0K
Apr 9, 2026Schayowitz AdamZYME
Award
76,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.